上海荣泰健康科技股份有限公司关于“荣泰转债”赎回结果暨股份变动的公告

Redemption Announcement - The company announced the redemption of its convertible bonds ("荣泰转债") due to the stock price meeting the required conditions for early redemption [2][3] - The stock price was above 130% of the conversion price of 23.07 CNY per share for 15 out of 30 trading days, triggering the redemption clause [2] Redemption Details - The board of directors approved the early redemption of the bonds at a price of 102.1713 CNY per bond, which includes accrued interest [4][8] - A total of 586,000 CNY (5,860 bonds) will be redeemed, with a total payout amount of 598,723.70 CNY including interest [5][12] - The redemption date is set for September 12, 2025, with the registration date for bondholders on September 11, 2025 [6][12] Conversion and Impact - As of September 11, 2025, 599,414,000 CNY of the bonds have been converted into 25,978,298 shares, representing 18.5559% of the company's total share capital before conversion [9] - The total share capital will increase to 203,355,564 shares after the redemption, which may dilute earnings per share in the short term but is expected to strengthen the company's capital structure for sustainable growth [13]